85-6834-45　Sutimlimab Biosimilar - Research Grade 10mg　ICH5012

特徴

• 背景：RUO sutimlimab biosimilar is a humanized monoclonal antibody that is designed to selectively target and inhibit C1s in the classical complement pathway, which is part of the innate immune system. By blocking C1s, sutimlimab inhibits the activation of the classical complement pathway with the goal of halting C1-activated hemolysis in cold agglutinin disease to prevent the abnormal destruction of healthy red blood cells. By selectively inhibiting the classical pathway upstream at C1s, sutimlimab does not inhibit the lectin and alternative complement pathways.

仕様

• サイズ：10mg
• ターゲット：C1s
• 交差性：Human
• 精製方法：This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
• 濃度：5mg/ml
• 構成：Sterile, preservative-free, solution in PBS. BSA and Azide free.
• 純度：>95% by SDS-PAGE
• エンドトキシン：≤ 1.0 EU/mg as determined by the LAL method
• 適用：Functional Assays
• データシート：https://ichor.bio/product/Sutimlimab-Biosimilar-Research-Grade-ICH5012?action=genpdf&id=81026
• この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]